Bladder, Colorectal, and Other Cancers
Under the CMS-HCC V28 risk adjustment model (PY2026 Medicare Advantage), HCC 22 carries a community non-dual aged RAF of 0.363, and 126 payable ICD-10-CM diagnosis codes map to it. In the V28 hierarchy it is superseded by HCC 17, HCC 18, HCC 19, HCC 20, HCC 21 when a more severe category in the same disease group is also present.
RAF factors
The community factor varies by Medicaid and originally-disabled status; the institutional factor applies to long-term-institutional members. These are the CMS-HCC V28 PY2026 relative factors.
V28 hierarchy
Trumped by: HCC 17, HCC 18, HCC 19, HCC 20, HCC 21 (a more severe category in the same disease group supersedes this one).
Supersedes: HCC 23 (this category is counted instead of these when they co-occur).
ICD-10-CM codes that map to HCC 22 (126)
Payable diagnosis codes that map to this category under CMS-HCC V28 PY2026. Open any code for its full description, HCC mapping, and coding guidance.
- C18.0Malignant neoplasm of cecum
- C18.1Malignant neoplasm of appendix
- C18.2Malignant neoplasm of ascending colon
- C18.3Malignant neoplasm of hepatic flexure
- C18.4Malignant neoplasm of transverse colon
- C18.5Malignant neoplasm of splenic flexure
- C18.6Malignant neoplasm of descending colon
- C18.7Malignant neoplasm of sigmoid colon
- C18.8Malignant neoplasm of overlapping sites of colon
- C18.9Malignant neoplasm of colon, unspecified
- C19Malignant neoplasm of rectosigmoid junction
- C20Malignant neoplasm of rectum
- C21.0Malignant neoplasm of anus, unspecified
- C21.1Malignant neoplasm of anal canal
- C21.2Malignant neoplasm of cloacogenic zone
- C21.8Malignant neoplasm of overlapping sites of rectum, anus and anal canal
- C26.0Malignant neoplasm of intestinal tract, part unspecified
- C26.1Malignant neoplasm of spleen
- C26.9Malignant neoplasm of ill-defined sites within the digestive system
- C51.0Malignant neoplasm of labium majus
- C51.1Malignant neoplasm of labium minus
- C51.2Malignant neoplasm of clitoris
- C51.8Malignant neoplasm of overlapping sites of vulva
- C51.9Malignant neoplasm of vulva, unspecified
- C52Malignant neoplasm of vagina
- C53.0Malignant neoplasm of endocervix
- C53.1Malignant neoplasm of exocervix
- C53.8Malignant neoplasm of overlapping sites of cervix uteri
- C53.9Malignant neoplasm of cervix uteri, unspecified
- C56.1Malignant neoplasm of right ovary
- C56.2Malignant neoplasm of left ovary
- C56.3Malignant neoplasm of bilateral ovaries
- C56.9Malignant neoplasm of unspecified ovary
- C57.00Malignant neoplasm of unspecified fallopian tube
- C57.01Malignant neoplasm of right fallopian tube
- C57.02Malignant neoplasm of left fallopian tube
- C57.10Malignant neoplasm of unspecified broad ligament
- C57.11Malignant neoplasm of right broad ligament
- C57.12Malignant neoplasm of left broad ligament
- C57.20Malignant neoplasm of unspecified round ligament
- C57.21Malignant neoplasm of right round ligament
- C57.22Malignant neoplasm of left round ligament
- C57.3Malignant neoplasm of parametrium
- C57.4Malignant neoplasm of uterine adnexa, unspecified
- C57.7Malignant neoplasm of other specified female genital organs
- C57.8Malignant neoplasm of overlapping sites of female genital organs
- C57.9Malignant neoplasm of female genital organ, unspecified
- C58Malignant neoplasm of placenta
- C64.1Malignant neoplasm of right kidney, except renal pelvis
- C64.2Malignant neoplasm of left kidney, except renal pelvis
- C64.9Malignant neoplasm of unspecified kidney, except renal pelvis
- C65.1Malignant neoplasm of right renal pelvis
- C65.2Malignant neoplasm of left renal pelvis
- C65.9Malignant neoplasm of unspecified renal pelvis
- C66.1Malignant neoplasm of right ureter
- C66.2Malignant neoplasm of left ureter
- C66.9Malignant neoplasm of unspecified ureter
- C67.0Malignant neoplasm of trigone of bladder
- C67.1Malignant neoplasm of dome of bladder
- C67.2Malignant neoplasm of lateral wall of bladder
- C67.3Malignant neoplasm of anterior wall of bladder
- C67.4Malignant neoplasm of posterior wall of bladder
- C67.5Malignant neoplasm of bladder neck
- C67.6Malignant neoplasm of ureteric orifice
- C67.7Malignant neoplasm of urachus
- C67.8Malignant neoplasm of overlapping sites of bladder
- C67.9Malignant neoplasm of bladder, unspecified
- C68.0Malignant neoplasm of urethra
- C68.1Malignant neoplasm of paraurethral glands
- C68.8Malignant neoplasm of overlapping sites of urinary organs
- C68.9Malignant neoplasm of urinary organ, unspecified
- C74.00Malignant neoplasm of cortex of unspecified adrenal gland
- C74.01Malignant neoplasm of cortex of right adrenal gland
- C74.02Malignant neoplasm of cortex of left adrenal gland
- C74.10Malignant neoplasm of medulla of unspecified adrenal gland
- C74.11Malignant neoplasm of medulla of right adrenal gland
- C74.12Malignant neoplasm of medulla of left adrenal gland
- C74.90Malignant neoplasm of unspecified part of unspecified adrenal gland
- C74.91Malignant neoplasm of unspecified part of right adrenal gland
- C74.92Malignant neoplasm of unspecified part of left adrenal gland
- C91.10Chronic lymphocytic leukemia of B-cell type not having achieved remission
- C91.11Chronic lymphocytic leukemia of B-cell type in remission
- C91.12Chronic lymphocytic leukemia of B-cell type in relapse
- C91.40Hairy cell leukemia not having achieved remission
- C91.41Hairy cell leukemia, in remission
- C91.42Hairy cell leukemia, in relapse
- C91.90Lymphoid leukemia, unspecified not having achieved remission
- C91.91Lymphoid leukemia, unspecified, in remission
- C91.92Lymphoid leukemia, unspecified, in relapse
- C91.Z0Other lymphoid leukemia not having achieved remission
- C91.Z1Other lymphoid leukemia, in remission
- C91.Z2Other lymphoid leukemia, in relapse
- C92.10Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
- C92.11Chronic myeloid leukemia, BCR/ABL-positive, in remission
- C92.12Chronic myeloid leukemia, BCR/ABL-positive, in relapse
- C92.40Acute promyelocytic leukemia, not having achieved remission
- C92.41Acute promyelocytic leukemia, in remission
- C92.42Acute promyelocytic leukemia, in relapse
- C95.10Chronic leukemia of unspecified cell type not having achieved remission
- C95.11Chronic leukemia of unspecified cell type, in remission
- C95.12Chronic leukemia of unspecified cell type, in relapse
- C95.90Leukemia, unspecified not having achieved remission
- C95.91Leukemia, unspecified, in remission
- C95.92Leukemia, unspecified, in relapse
- D3A.00Benign carcinoid tumor of unspecified site
- D3A.010Benign carcinoid tumor of the duodenum
- D3A.011Benign carcinoid tumor of the jejunum
- D3A.012Benign carcinoid tumor of the ileum
- D3A.019Benign carcinoid tumor of the small intestine, unspecified portion
- D3A.020Benign carcinoid tumor of the appendix
- D3A.021Benign carcinoid tumor of the cecum
- D3A.022Benign carcinoid tumor of the ascending colon
- D3A.023Benign carcinoid tumor of the transverse colon
- D3A.024Benign carcinoid tumor of the descending colon
- D3A.025Benign carcinoid tumor of the sigmoid colon
- D3A.026Benign carcinoid tumor of the rectum
- D3A.029Benign carcinoid tumor of the large intestine, unspecified portion
- D3A.090Benign carcinoid tumor of the bronchus and lung
- D3A.091Benign carcinoid tumor of the thymus
- D3A.092Benign carcinoid tumor of the stomach
- D3A.093Benign carcinoid tumor of the kidney
- D3A.094Benign carcinoid tumor of the foregut, unspecified
- D3A.095Benign carcinoid tumor of the midgut, unspecified
- D3A.096Benign carcinoid tumor of the hindgut, unspecified
- D3A.098Benign carcinoid tumors of other sites
- D3A.8Other benign neuroendocrine tumors
Frequently asked questions
What is CMS-HCC V28 category 22?
HCC 22 is "Bladder, Colorectal, and Other Cancers", a payment Hierarchical Condition Category in the CMS-HCC V28 risk adjustment model (100% phase-in for payment year 2026). 126 payable ICD-10-CM codes map to it.
What is the RAF weight for HCC 22?
The community non-dual aged relative factor for CMS-HCC V28 category 22 is 0.363. The exact factor varies by enrollment segment (community Medicaid and originally-disabled status, and institutional); the full segment table is published in the CMS V28 Rate Announcement.
How many ICD-10-CM codes map to HCC 22?
126 payable ICD-10-CM diagnosis codes map to CMS-HCC V28 category 22 (Bladder, Colorectal, and Other Cancers) for payment year 2026.
Which categories trump HCC 22 in the V28 hierarchy?
HCC 22 is superseded by HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic), HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid), HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers), HCC 20 (Lung and Other Severe Cancers), HCC 21 (Lymphoma and Other Cancers). When a more severe category in the same disease group is documented, it is counted instead of HCC 22.
Source: CMS published ICD-10-CM mapping file plus CMS-HCC v28 PY2026 model software.